Matt TurnerPatient Affordability
Paul TheisenPatient Acquisition
Daniel SontupeMarket Access
Suma Ramadas, PhDMedical Affairs
Stacey GandlerBrand Nourishment
David LinetskyPoint-of-Care Marketing
Amy GilesIncreasing Engagement
Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
Joey CohenMedication Adherence
Matthew DurhamOmnidynamic Marketing
Liz KaneImpactful Strategy
Frank BurrellScientific Storytelling
Brenda SnowAuthentic Patient Voice
ADVM-022 is the first intravitreally delivered gene therapy utilizing directed evolution AAV.7m8 vector for ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email